血浆ACSL4浓度及变化趋势与LAA型急性缺血性脑卒中的相关研究
Correlation between Trends in Plasma ACSL4 Levels and Prognosis of Acute Ischaemic Stroke of the Large Artery Atherosclerosis
DOI: 10.12677/acm.2025.1571994, PDF,    国家自然科学基金支持
作者: 邢乘风*, 马爱军#:青岛大学青岛医学院,山东 青岛;青岛大学附属医院神经内科,山东 青岛
关键词: 脑卒中铁死亡ACSL4动脉粥样硬化Stroke Ferroptosis ACSL4 Atherosclerosis
摘要: 目的:动脉粥样硬化是常见的脑卒中危险因素之一,LAA型急性缺血性脑卒中患者的风险及临床结局预测对临床诊治至关重要。本研究旨在探讨血浆ACSL4浓度与LAA型急性缺血性脑卒中以及90天功能结局、安全结局和颈动脉粥样硬化斑块稳定性的关系,进一步为LAA型急性缺血性脑卒中的临床诊疗提供有价值的参考。方法:纳入146名确诊为LAA型脑梗死的患者和122名性别和年龄匹配的健康体检患者作为对照组。分析ACSL4血浆浓度及变化趋势与LAA型脑卒中患者的预后和颈动脉斑块稳定性的相关性。结果:对比健康人群,LAA型急性缺血性脑卒中患者血浆ACSL4水平升高(P < 0.05),持续7天以上;在LAA型急性缺血型脑卒中患者中,脑卒中较严重的患者,血浆ACSL4水平较高,变化差异较明显;功能结局差的患者,血浆ACSL4水平较高(P < 0.05),变化差异较明显;安全结局较差的患者,血浆ACSL4水平变化差异较明显(P < 0.05);颈动脉斑块稳定性较差的患者,血浆ACSL4水平及变化差异均较明显(P < 0.05)。结论:LAA型急性缺血性脑卒中患者血浆ACSL4水平升高,与严重程度呈正相关,可作为LAA型急性缺血性脑卒中的独立危险因素。同时与较差的功能结局及颈动脉斑块稳定性呈正相关关系,血浆ACSL4变化水平较大导致较差的90 d安全结局及颈动脉斑块稳定性。
Abstract: Objective: Atherosclerosis is one of the common risk factors for stroke. The risk and clinical outcome prediction of patients with LAA-AIS are crucial for clinical diagnosis and treatment. This study aims to explore the relationship between plasma ACSL4 concentration and LAA-AIS, as well as 90-day functional outcomes, safety outcomes, and the stability of carotid atherosclerotic plaques, and further provide valuable references for the clinical diagnosis and treatment of LAA-AIS. Methods: 146 patients diagnosed with LAA-AIS and 122 healthy patients who underwent physical examinations and were matched by gender and age were included as the control group. To analyze the correlation between the plasma concentration and changing trend of ACSL4 and the prognosis and carotid plaque stability of patients with LAA-AIS. Results: Compared with the healthy population, the plasma ACSL4 level of patients with LAA-AIS increased (P < 0.05), lasting for more than 7 days; Among patients with LAA-AIS, those with more severe stroke have higher plasma ACSL4 levels, and the differences in changes are more obvious. Patients with poor functional outcomes had higher plasma ACSL4 levels (P < 0.05), and the difference in change was more obvious. Patients with poor safety outcomes had more significant differences in the changes of plasma ACSL4 levels (P < 0.05); Patients with poor stability of carotid artery plaques had more significant differences in plasma ACSL4 levels and changes (P < 0.05). Conclusion: The plasma ACSL4 level in patients with LAA-AIS is elevated and positively correlated with the severity, which can be regarded as an independent risk factor for LAA-AIS. At the same time, it was positively correlated with poor functional outcomes and carotid plaque stability. A large level of change in plasma ACSL4 led to poor 90-day safety outcomes and carotid plaque stability.
文章引用:邢乘风, 马爱军. 血浆ACSL4浓度及变化趋势与LAA型急性缺血性脑卒中的相关研究[J]. 临床医学进展, 2025, 15(7): 333-349. https://doi.org/10.12677/acm.2025.1571994

参考文献

[1] Ma, Y., Zhao, X., Zhang, W., Liu, L., Wang, Y., Fang, R., et al. (2010) Homocysteine and Ischemic Stroke Subtype: A Relationship Study in Chinese Patients. Neurological Research, 32, 636-641. [Google Scholar] [CrossRef] [PubMed]
[2] Adams, H.P., Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B., Gordon, D.L., et al. (1993) Classification of Subtype of Acute Ischemic Stroke. Definitions for Use in a Multicenter Clinical Trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 24, 35-41. [Google Scholar] [CrossRef] [PubMed]
[3] Bailey, E.L., Smith, C., Sudlow, C.L.M. and Wardlaw, J.M. (2012) Pathology of Lacunar Ischemic Stroke in Humans—A Systematic Review. Brain Pathology, 22, 583-591. [Google Scholar] [CrossRef] [PubMed]
[4] Libby, P. (2021) The Changing Landscape of Atherosclerosis. Nature, 592, 524-533. [Google Scholar] [CrossRef] [PubMed]
[5] Ni, T., Fu, Y., Zhou, W., Chen, M., Shao, J., Zhou, W., et al. (2020) Carotid Plaques and Neurological Impairment in Patients with Acute Cerebral Infarction. PLOS ONE, 15, e0226961. [Google Scholar] [CrossRef] [PubMed]
[6] Li, C., Sun, G., Chen, B., Xu, L., Ye, Y., He, J., et al. (2021) Nuclear Receptor Coactivator 4-Mediated Ferritinophagy Contributes to Cerebral Ischemia-Induced Ferroptosis in Ischemic Stroke. Pharmacological Research, 174, Article ID: 105933. [Google Scholar] [CrossRef] [PubMed]
[7] Hu, Y., Li, Q. and Wang, Y. (2024) Serum ACSL4 Levels in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) and Its Association with One-Year Major Adverse Cardiovascular Events (MACE): A Prospective Cohort Study. Medicine, 103, e36870. [Google Scholar] [CrossRef] [PubMed]
[8] Wu, Y., Sun, Y., Wu, Y., Zhang, K. and Chen, Y. (2023) Predictive Value of Ferroptosis-Related Biomarkers for Diabetic Kidney Disease: A Prospective Observational Study. Acta Diabetologica, 60, 507-516. [Google Scholar] [CrossRef] [PubMed]
[9] Zhao, P., Lv, X., Zhou, Z., Yang, X., Huang, Y. and Liu, J. (2023) Indexes of Ferroptosis and Iron Metabolism Were Associated with the Severity of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. Frontiers in Endocrinology, 14, Article 1297166. [Google Scholar] [CrossRef] [PubMed]
[10] Yu, W., Wang, L., Liu, S., Liu, Y., Wang, S. and Sun, X. (2023) Combination of Serum ACSL4 Levels and Low-Dose 256-Slice Spiral CT Exhibits the Potential in the Early Screening of Lung Cancer. Medicine, 102, e32733. [Google Scholar] [CrossRef] [PubMed]
[11] Kram, H., Prokop, G., Haller, B., Gempt, J., Wu, Y., Schmidt-Graf, F., et al. (2022) Glioblastoma Relapses Show Increased Markers of Vulnerability to Ferroptosis. Frontiers in Oncology, 12, Article 841418. [Google Scholar] [CrossRef] [PubMed]
[12] Belkaid, A., Ouellette, R.J. and Surette, M.E. (2017) 17β-Estradiol-Induced ACSL4 Protein Expression Promotes an Invasive Phenotype in Estrogen Receptor Positive Mammary Carcinoma Cells. Carcinogenesis, 38, 402-410. [Google Scholar] [CrossRef] [PubMed]
[13] Gubern, C., Camós, S., Ballesteros, I., Rodríguez, R., Romera, V.G., Cañadas, R., et al. (2013) Mirna Expression Is Modulated over Time after Focal Ischaemia: Up‐Regulation of miR-347 Promotes Neuronal Apoptosis. The FEBS Journal, 280, 6233-6246. [Google Scholar] [CrossRef] [PubMed]
[14] Jin, Z., Gao, W., Guo, F., Liao, S., Hu, M., Yu, T., et al. (2023) Ring Finger Protein 146-Mediated Long-Chain Fatty-Acid-Coenzyme a Ligase 4 Ubiquitination Regulates Ferroptosis-Induced Neuronal Damage in Ischemic Stroke. Neuroscience, 529, 148-161. [Google Scholar] [CrossRef] [PubMed]
[15] Chen, J., Yang, L., Geng, L., He, J., Chen, L., Sun, Q., et al. (2021) Inhibition of Acyl-Coa Synthetase Long-Chain Family Member 4 Facilitates Neurological Recovery after Stroke by Regulation Ferroptosis. Frontiers in Cellular Neuroscience, 15, Article 632354. [Google Scholar] [CrossRef] [PubMed]
[16] Tang, F., Zhou, L., Li, P., Jiao, L., Chen, K., Guo, Y., et al. (2023) Inhibition of ACSL4 Alleviates Parkinsonism Phenotypes by Reduction of Lipid Reactive Oxygen Species. Neurotherapeutics, 20, 1154-1166. [Google Scholar] [CrossRef] [PubMed]
[17] Picano, E. and Paterni, M. (2015) Ultrasound Tissue Characterization of Vulnerable Atherosclerotic Plaque. International Journal of Molecular Sciences, 16, 10121-10133. [Google Scholar] [CrossRef] [PubMed]
[18] Yuan, H., Li, X., Zhang, X., Kang, R. and Tang, D. (2016) Identification of ACSL4 as a Biomarker and Contributor of Ferroptosis. Biochemical and Biophysical Research Communications, 478, 1338-1343. [Google Scholar] [CrossRef] [PubMed]
[19] Kenny, E.M., Fidan, E., Yang, Q., Anthonymuthu, T.S., New, L.A., Meyer, E.A., et al. (2019) Ferroptosis Contributes to Neuronal Death and Functional Outcome after Traumatic Brain Injury. Critical Care Medicine, 47, 410-418. [Google Scholar] [CrossRef] [PubMed]
[20] Zhu, Z., Liu, Y., Gong, Y., Jin, W., Topchiy, E., Turdi, S., et al. (2021) Mitochondrial Aldehyde Dehydrogenase (ALDH2) Rescues Cardiac Contractile Dysfunction in an APP/PS1 Murine Model of Alzheimer’s Disease via Inhibition of Acsl4-Dependent Ferroptosis. Acta Pharmacologica Sinica, 43, 39-49. [Google Scholar] [CrossRef] [PubMed]
[21] Weiland, A., Wang, Y., Wu, W., Lan, X., Han, X., Li, Q., et al. (2018) Ferroptosis and Its Role in Diverse Brain Diseases. Molecular Neurobiology, 56, 4880-4893. [Google Scholar] [CrossRef] [PubMed]
[22] Ahmad, S., Elsherbiny, N.M., Haque, R., Khan, M.B., Ishrat, T., Shah, Z.A., et al. (2014) Sesamin Attenuates Neurotoxicity in Mouse Model of Ischemic Brain Stroke. NeuroToxicology, 45, 100-110. [Google Scholar] [CrossRef] [PubMed]
[23] Cui, Y., Zhang, Y., Zhao, X., Shao, L., Liu, G., Sun, C., et al. (2021) ACSL4 Exacerbates Ischemic Stroke by Promoting Ferroptosis-Induced Brain Injury and Neuroinflammation. Brain, Behavior, and Immunity, 93, 312-321. [Google Scholar] [CrossRef] [PubMed]
[24] Tuo, Q., Liu, Y., Xiang, Z., Yan, H., Zou, T., Shu, Y., et al. (2022) Thrombin Induces ACSL4-Dependent Ferroptosis during Cerebral Ischemia/Reperfusion. Signal Transduction and Targeted Therapy, 7, Article No. 59. [Google Scholar] [CrossRef] [PubMed]
[25] Ding, K., Liu, C., Li, L., Yang, M., Jiang, N., Luo, S., et al. (2023) Acyl-CoA Synthase ACSL4: An Essential Target in Ferroptosis and Fatty Acid Metabolism. Chinese Medical Journal, 136, 2521-2537. [Google Scholar] [CrossRef] [PubMed]
[26] Doll, S., Proneth, B., Tyurina, Y.Y., Panzilius, E., Kobayashi, S., Ingold, I., et al. (2016) ACSL4 Dictates Ferroptosis Sensitivity by Shaping Cellular Lipid Composition. Nature Chemical Biology, 13, 91-98. [Google Scholar] [CrossRef] [PubMed]
[27] Zhang, M., Yu, Z., Zhao, L. and Luo, H. (2023) Long Non-Coding RNA PVT1 Regulates Atherosclerosis Progression via the MicroRNA-106b-5p/ACSL4 Axis. Biochemical and Biophysical Research Communications, 667, 170-179. [Google Scholar] [CrossRef] [PubMed]
[28] Ferronato, S., Scuro, A., Fochi, S., Orlandi, E., Gomez-Lira, M., Olivato, S., et al. (2018) Expression of TLR4-PTGE2 Signaling Genes in Atherosclerotic Carotid Plaques and Peripheral Blood. Molecular Biology Reports, 46, 1317-1321. [Google Scholar] [CrossRef] [PubMed]
[29] Ferronato, S., Scuro, A., Gomez-Lira, M., Mazzucco, S., Olivato, S., Turco, A., et al. (2018) Correlations between Gene Expression Highlight a Different Activation of ACE/TLR4/PTGS2 Signaling in Symptomatic and Asymptomatic Plaques in Atherosclerotic Patients. Molecular Biology Reports, 45, 657-662. [Google Scholar] [CrossRef] [PubMed]